Expectancies in Migraine Patients
EXPMIG
Expectancies About Positive Outcomes and Their Possible Potentiating Role of Standard Treatment in Migraine Patients
1 other identifier
interventional
102
1 country
1
Brief Summary
The aim of the present study is to examine whether the standard treatment prescribed to migraine patients is potentiated when coupled with a verbal instruction inducing more hope and optimism. In order to achieve the goal, outpatients with low-frequency episodic migraine diagnoses (\<8 attacks per month) and outpatients with chronic migraine diagnoses (\>15 attacks per month) will be screened and enrolled, thereafter they will be exposed to verbal instruction inducing more hope and optimism or to verbal instruction inducing hope and optimism together with standard treatment. We hypothesize that the group receiving verbal instruction inducing more hope and optimism would develop larger improvements in all outcome measures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
October 7, 2024
CompletedFirst Posted
Study publicly available on registry
October 9, 2024
CompletedOctober 15, 2024
October 1, 2024
2 years
October 7, 2024
October 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Headache Impact Test
self-report scale assessing the disability due to migraine
baseline, 7-day, 15-day, 1- and 3-month follow-ups
Intensity of migraine
A Numeric Rating Scale (NRS) assessing the intensity of migraine pain on a 11-point NRS (0 = no pain, 10 = worst imaginable pain) during the last migraine attack
baseline, 7-day, 15-day, 1- and 3-month follow-ups
Secondary Outcomes (1)
Expectancies
baseline, 7-day, 15-day, 1- and 3-month follow-ups
Study Arms (2)
instructions inducing hope and optimism
EXPERIMENTALThe verbal instruction inducing more hope and optimism will be: "The present therapy is a very effective one for your specific type of headache. By taking it, a large number of patients experienced significant pain relieve and improvement in functional capacity
neutral instructions
PLACEBO COMPARATORThe verbal instruction inducing hope and optimism will be: "The present therapy is an effective one for your specific type of headache. By taking it, a large number of patients experienced pain relieve and improvement in functional capacity".
Interventions
verbal instructions inducing hope and optimism were administered as experimental condition vs neutral instructions (i.e., instructions not able to induce hope and optimism although realistic ones)
Eligibility Criteria
You may qualify if:
- Incident or prevalent diagnosis of low-frequency episodic migraine or chronic migraine according to ICHD criteria version 3 beta 2013.
- Age of at least 18 years.
- Signature of informed consent.
You may not qualify if:
- Standard treatment proposed different from topiramate, amitriptyline, valproate, β-blockers.
- Inability to understand and want.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fiammetta COSCI
Florence, 50135, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- participants did not know whether they were allocated to the control or the experimental condition
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 7, 2024
First Posted
October 9, 2024
Study Start
January 1, 2022
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
October 15, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share
IPD were made available only to the researchers directly involved in the data collection.